Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: A study using monoclonal antibodies raised against relevant peptides

AIDS Research and Human Retroviruses

Volumn 15, Issue 10, 1999, Pages 909-920

  Londos Gagliardi, D ^a,b   Jauvin, V ^a,b   Armengaut, M H ^a,b   Astier Gin, T ^a,b   Goetz, M ^c   Huet, S ^a   Guillemain, B J ^a,b  

^a INSTITUT BERGONIÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

AMINO ACID SUBSTITUTION; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMORAL IMMUNITY; PEPTIDE SYNTHESIS; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; REPORTER GENE; TARGET CELL; VIRUS ENVELOPE; VIRUS ISOLATION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DELTARETROVIRUS ANTIBODIES; DELTARETROVIRUS ANTIGENS; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE PRODUCTS, ENV; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOBLOTTING; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN ISOTYPES; LIVER; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; RETROVIRIDAE PROTEINS, ONCOGENIC; VERO CELLS;

EID: 0033168672     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310629     Document Type: Article

References (46)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, and Gallo RC: Detection and isolation of type C retroviruses particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
2. Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, and Hinuma Y: Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukemic T-cells. Nature (London) 1981;294:770-771.
3. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calendar A, and De Thé G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2:407-410.
4. Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, and Igata A: Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type 1 and adult T-cell leukemialike cells. Ann Neurol 1987;21:117-122.
5. Ohba N, Matsumoto M, Sameshima M, Kabayama Y, Nakano K, Unoki K, Uehara F, Kawano K, Maruyama I, and Osame M: Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol 1989;33:1-12.
6. Hajjar C, Sainte Foie S, Savin J, Lacave J, Beriet F, Teron-Aboud B, Batelier L, and Guillemain B: Infection à HTLV1 et syndrome sec. J Fr Ophthalmol 1995;18:597-602.
7. Gary RF: New evidence for involvement of retroviruses in Sjögren's syndrome and other autoimmune diseases. Arth Rheum 1994;37:465-469.
8. La Grenade L, Hanchard B, Fletcher V, Cranston B, and Blattner W: Infective dermatitis of Jamaican children: A marker for HTLV-I infection. Lancet 1990;336:1345-1347.
9. Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, Araki S, and Kawasaki S: T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 1987;2:1220.
10. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, and Osame M: Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989;1:441.
11. Evans BK, Gore I, Harrell LE, Arnold T, and Oh SJ: HTLV-I-associated myelopathy and polymyositis in US native. Neurology 1989;39:1572-1575.
12. Shida H, Tochikura T, Sato T, Konno T, Hirayoshi K, Seki M, Ito Y, Hatanaka M, Hinuma Y, Sugimoto M, Takahashi-Nishimaki F, Maruyama T, Miki K, Suzuki K, Monta M, Sashiyama H, and Hayami M: Effect of the recombinant vaccinia viruses that express HTLV-I envelope glycoprotein on HTLV-I infection. EMBO J 1987;6:3379-3384.
13. Nakamura H, Hayami M, Ohta Y, Ishikawa KI, Tsujimoto H, Kiyokawa T, Yoshida M, Sasagawa A, and Honjo S: Protection of cynomolgus monkeys against infection by human T-cell leukemia virus type-I by immunization with viral env gene products produced in Escherichia coli. Int J Cancer 1987;40:403-407.
14. Ratner L, Philpott T, and Trowbridge DB: Nucleotide sequence analysis of isolates of human T-lymphotropic virus type 1 of diverse geographical origins. AIDS Res Hum Retroviruses 1991; 7:923-941.
15. Gessain A, Boeri E, Yanagihara R, Gallo RC, and Franchini G: Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from Melanesia: Genetic and phylogenetic relationship to HTLV-I strains from other geographical regions. J Virol 1993;67: 1015-1023.
16. Horal P, Hall WW, Svennerholm B, Lycke J, Jeansson S, Rymo L, Kaplan MH, and Vahlne A: Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia virus type I and type II using synthetic peptides. Proc Natl Acad Sci USA 1991;88:5754-5758.
17. Tanaka Y, Zeng L, Shiraki H, Shida H, and Tozawa H: Identification of a neutralization epitope on the envelope gp46 antigen of human T-cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J Immunol 1991; 147:354-360.
18. Kuroki M, Nakamura M, Itoyama Y, Tanaka Y, Shiraki H, Baba E, Esaki T, Tatsumoto T, Nagafuchi S, Nakano S, and Niho Y: Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibodies-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1. J Immunol 1992;149:940-948.
19. Baba E, Nakamura M, Tanaka Y, Kuroki M, Itoyama Y, Nakano S, and Niho Y: Multiple neutralising B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. J Immunol 1993;151:1013-1024.
20. Malik KTA, Even J, and Karpas A: Molecular cloning and complete nucleotide sequence of an adult T-cell leukemia virus/human T-cell leukemia virus type I (ATLV/HTLV-I) isolate of Caribbean origin: Relationship to other members of the ATLV/HTLV-I subgroup. J Gen Virol 1988;69:1695-1710.
21. Moynet D, Cosnefroy JY, Bedjabaga I, Roelants G, Georges-Courbot MC, and Guillemain B: Identification of new genetic subtypes of human T cell leukemia virus type I in Gabon from encoding sequence of surface envelope glycoprotein. AIDS Res Hum Retroviruses 1995;11:1407-1411.
22. Edouard E, Londos-Gagliardi D, Busetta B, Geoffre S, Dalbon P, Moreau JP, and Guillemain B: Recognition by human sera of a variable region of the surface glycoprotein of HTLV-I. Leukemia 1994;8:S65-S67.
23. Lal RB, Rudolph DL, Palker TJ, Coligan JE, and Folks TM: A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I. J Gen Virol 1991;72:2321-2324.
24. Londos-Gagliardi D, Dalibart R, Geoffre S, Dalbon P, Pouliquen JF, Georges-Courbot MC, Sainte-Foie S, Hajjar C, Georges AJ, Moreau JP, and Guillemain B: Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region. AIDS Res Hum Retroviruses 1996;12:941-950.
25. Kohtz DS, Altman A, Kohtz JD, and Puszkin S: Immunological and structural homology between human T-cell leukemia virus type I envelope glycoprotein and a region of human interleukin-2 implicating in binding the β receptor. J Virol 1988;62:659-662.
26. Lal RB: Structural similarity of envelope glycoprotein of HTLV-I and C-terminal region of v-erbB and EGF receptor. AIDS Res Hum Retroviruses 1991;7:423-424.
27. De Thé G and Bomford R: An HTLV-I vaccine: Why, how, for whom? AIDS Res Hum Retroviruses 1993;9:381-386.
28. Blanchard S, Astier-Gin T, Moynet D, Edouard E, and Guillemain B: Different HTLV-I neutralization patterns among sera of patients infected with cosmopolitan HTLV-I. Virology 1998;245:90-98.
29. Schulz TF, Calabro ML, Hoad JG, Carrington CVF, Matutes E, Catovsky D, and Weiss RA: HTLV-I envelope sequences from Brazil, the Caribbean, and Romania: Clustering of sequences according to geographical origin and variability in an antibody epitope. Virology 1991;184:483-491.
30. Edouard E, Legrand E, Astier-Gin T, Dalibart R, Geoffre S, Dalbon P, Guillemain B, and Londos-Gagliardi D: Characterization of monoclonal antibodies directed against the gp46 of human T-cell leukemia virus type I. Leukemia 1994;8:S60-S64.
31. Nicot C, Astier-Gin T, Edouard E, Legrand E, Moynet D, Vital A, Londos-Gagliardi D, Moreau JP, and Guillemain B: Establishment of HTLV-I infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles. Virus Res 1993;30:317-334.
32. Popovic M, Lange-Wantzin G, Sarin PS, Mann D, and Gallo RC: Transformation of human umbilical cord bloot T cells by human T-cell leukemia/lymphoma virus. Proc Natl Acad Sci USA 1983;80:5402-5406.
33. Gallo D, Penning LM, and Hanson CV: Detection and differentiation of antibodies to human T-cell lymphotropic virus type I and II by the immunofluorescence method. J Clin Microbiol 1991; 10:2345-2347.
34. Huang CC, Hou Y, Woods LK, Moore GE, and Minowada J: Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia. J Natl Cancer Inst 1974;53:655-660.
35. Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, and McCarthy RE: Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 1965; 18:2749-2754.
36. Shulman M, Wilde CD, and Kohler G: A better line for making hybridomas secreting specific antibodies. Nature (London) 1978;276:269-270.
37. Astier-Gin T, Portail JP, Lafond B, and Guillemain B: Identification of HTLV-I- or HTLV-II-producing cells by cocultivation with BHK-21 cells stably transfected with a LTR-lacZ gene construct. J Virol Methods 1995;51:19-30.
38. Simizu B, Rhim JS, and Wiebenga NH: Characterization of the Tacaribe group of arboviruses. I. Propagation and plaque assay of Tacaribe virus in a line of African green monkey kidney cells (Vero). Proc Soc Exp Biol Med 1967;125:119-123.
39. Seiki M, Hattori S, Hirayama Y, and Yoshida M: Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 1983;80:3618-3622.
40. Gray GS, White M, Bartman T, and Mann D: Envelope gene sequence of HTLV-I isolate MT-2 and its comparison with other HTLV-I isolates. Virology 1990;177:391-395.
41. Bauminger S and Wilchek M: The use of carbodiimides in the preparation of immunizing conjugates. Methods Enzymol 1980;70:151-159.
42. Astier-Gin T, Portail JP, Londos-Gagliardi D, Moynet D, Blanchard S, Dalibart R, Pouliquen JF, Georges-Courbot MC, Hajjar C, Sainte-Foie S, and Guillemain B: Neutralizing activity and antibody reactivity toward immunogenic regions of the human T cell leukemia virus type I surface glycoprotein in sera of infected patients with different clinical states. J Infect Dis 1997;175:716-719.
43. Goetz M, Picard P, Londos-Gagliardi D, Guillemain B, and Precigoux G: Immunoreactivity and conformation of the immunodominant domain of HTLV-I envelope surface glycoprotein. Lett Peptide Sci 1997;4:351-358.
44. Benson J, Tschachler E, Gessain A, Yanagihara R, Gallo RC, and Franchini G: Cross-neutralization antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands. AIDS Res Hum Retroviruses 1994;10:91-96.
45. Grange MP, Rosenberg AR, Horal P, and Desgranges C: Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I). Int J Cancer 1998;75:804-813.
46. Carrington CVF, Paul N, Cordell J, and Schulz TF: Probing the conformation of the human T-lymphotropic virus I envelope protein complex with monoclonal antibodies. J Gen Virol 1996;77: 2025-2029.